In vivo studies showed that second generation CAR T-cells had superior expansion in response to the antigen, provided protection to CD4+ T-cells against HIV infection, and CD4 reduction was decreased compared to the CARs without costimulatory molecules (Leibman et al., 2017). This evidence concerns the gene CD4 and HIV infectious disease.